图书馆订阅: Guest
肿瘤形成评论综述™

每年出版 4 

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis

卷 22, 册 1-2, 2017, pp. 49-61
DOI: 10.1615/CritRevOncog.2017020473
Get accessGet access

摘要

There have been recent developments in the treatment of various cancers, in particular non-metastatic cancers. However, many of the responding patients often relapse initially through the development of spread micro and macro-metastases. Unfortunately, there are very few therapeutic modalities for the treatment of metastatic cancers. The development of cancer metastasis has been proposed to involve the epithelial–mesenchymal transition (EMT), in which the tumor cells with the EMT phenotype exhibit various phenotypic markers and molecular modifications that are manifested to resist most conventional therapies. YY1 is a target of the hyperactivated nuclear factor-kappa beta pathway in cancer and it was reported that YY1 also regulates cell survival and cell proliferation in addition to its role in EMT and resistance. The overexpression of YY1 in the majority of cancers has been correlated with poor prognosis. It is hypothesized that targeting YY1 may result in several anti-tumor activities, including inhibition of cell survival and cell proliferation, inhibition of EMT, and reversal of resistance. This review discusses the potential therapeutic targeting of an overexpressed transcription factor, Yin Yang 1 (YY1), which has been implicated in the development of EMT and drug resistance. Several examples targeting YY1 in experimental models are presented.

对本文的引用
  1. Hasan Nesrin, Ahuja Nita, The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer, Cancers, 11, 12, 2019. Crossref

  2. Yang Tingting, Shu Fanglin, Yang Hao, Heng Cai, Zhou Yi, Chen Yibing, Qian Xuan, Du Lei, Zhu Xia, Lu Qian, Yin Xiaoxing, YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis, Metabolism, 96, 2019. Crossref

  3. Jinesh Goodwin G., Brohl Andrew S., The genetic script of metastasis, Biological Reviews, 95, 1, 2020. Crossref

  4. Hays Emily, Bonavida Benjamin, YY1 regulates cancer cell immune resistance by modulating PD-L1 expression, Drug Resistance Updates, 43, 2019. Crossref

  5. Özenver Nadire, Efferth Thomas, Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  6. Xu Yanyan, Wang Jing, Ding Hong, Regulation of epithelial–mesenchymal transition via sonic hedgehog/glioma‐associated oncogene homolog 1 signaling pathway in peritoneal mesothelial cells, Cell Biology International, 44, 8, 2020. Crossref

  7. Hong Weiguo , Hu Yan , Fan Zhenping , Gao Rong , Yang Ruichuang , Bi Jingfeng , Hou Jun , In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse, Oncology Letters, 2019. Crossref

  8. Zhang Lei, Zou Lei, Sun Peng, Relationship between miR-378c and YY1 expression in patients with gastric cancer and the clinicopathological features, Cellular & Molecular Biology Letters, 26, 1, 2021. Crossref

  9. Bhaskar Rao Divya, Panneerpandian Ponmathi, Balakrishnan Karthik, Ganesan Kumaresan, YY1 regulated transcription‐based stratification of gastric tumors and identification of potential therapeutic candidates, Journal of Cell Communication and Signaling, 15, 2, 2021. Crossref

  10. Barrero Maria Jose, Targeting YY1 in cancer through histone acetylation, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  11. Shen Bin, Li Yang, Ye Qian, Qin Youyou, YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer, Cancer Gene Therapy, 28, 10-11, 2021. Crossref

  12. Padam Kanaka Sai Ram, Chakrabarty Sanjiban, Kabekkodu Shama Prasada, Paul Bobby, Hunter Keith D, Radhakrishnan Raghu, In silico analysis of HOX-associated transcription factors as potential regulators of oral cancer, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 132, 1, 2021. Crossref

  13. Michele Gabriele, Giuseppe Testa, Anders Hansen, Molecular mechanisms of YY1 overexpression in human cancers and its prognostic significance, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  14. Meliala Ian Timothy Sembiring, Hosea Rendy, Kasim Vivi, Wu Shourong, Yin and Yang of YY1 regulation on tumor metabolic reprogramming, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  15. Li Yanjun, Meliala Ian Timothy Sembiring, Wei Mankun, Kasim Vivi, YY1 and tumor metastasis regulation, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  16. Wang Yuhao, Bonavida Benjamin, The role of YY1 in the pathogenesis of rheumatoid arthritis: A tale of cytokines, ncRNAs, and aberrant fibroblast-like synoviocytes (FLSs), in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  17. Touboul Roni, Bonavida Benjamin, YY1 expression and PD-1 regulation in CD8 T lymphocytes, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  18. Panneerpandian Ponmathi, Rao Divya Bhaskar, Ganesan Kumaresan, Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin, Toxicology in Vitro, 74, 2021. Crossref

  19. Zhang Shuya, Kim Ji Young, Xu Suowen, Liu Huan, Yin Meimei, Koroleva Marina, Guo Jia, Pei Xiuying, Jin Zheng Gen, Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ, Proceedings of the National Academy of Sciences, 117, 9, 2020. Crossref

  20. Qiao Shiyao, Wang Wenmeng, Yi Cheng, Xu Qingqing, Wang Wenfei, Shi Jinming, Stovall Daniel B., Li Dangdang, Sui Guangchao, YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins, Cancers, 14, 7, 2022. Crossref

  21. Zhou Xumin, Zou Libin, Liao Hangyu, Luo Junqi, Yang Taowei, Wu Jun, Chen Wenbin, Wu Kaihui, Cen Shengren, Lv Daojun, Shu Fangpeng, Yang Yu, Li Chun, Li Bingkun, Mao Xiangming, Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer, Acta Pharmaceutica Sinica B, 12, 2, 2022. Crossref

  22. Sato Nami, Sakai Nozomu, Furukawa Katsunori, Takayashiki Tsukasa, Kuboki Satoshi, Takano Shigetsugu, Ohira Gaku, Matsubara Hisahiro, Ohtsuka Masayuki, Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer, Oncology Reports, 47, 5, 2022. Crossref

  23. Kwiatkowska Dominika, Mazur Ewelina, Reich Adam, YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance, Frontiers in Oncology, 12, 2022. Crossref

  24. Xueqin Tao, Jinhong Mei, Yuping Huang, Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway, Bioengineered, 12, 2, 2021. Crossref

  25. Luo Can, Chen Xin, Bai Yuting, Xu Lei, Wang Shuqi, Yao Lihua, Guo Xiaolan, Wang Dongsheng, Zhong Xiaowu, Falzone Luca, Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma, International Journal of Genomics, 2022, 2022. Crossref

  26. Morales-Martínez Mario, Vega Mario I., Roles and Regulation of BCL-xL in Hematological Malignancies, International Journal of Molecular Sciences, 23, 4, 2022. Crossref

  27. Li Qiumin, Wang Ying, Liu Feifei, Wang Haili, Fan Yangyang, Liao Zhijun, LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment, BioMed Research International, 2022, 2022. Crossref

  28. Zhou Shumin, Li Pin, Qin Li, Huang Shuhong, Dang Ningning, Transcription factor YY1 contributes to human melanoma cell growth through modulating the p53 signalling pathway, Experimental Dermatology, 31, 10, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain